Recent research has shown that Rg5 inhibits glioblastoma progression by activating nuclear receptor subfamily 3 group C member 1 (NR3C1), thereby regulating heat shock protein family B member 1 (HSPB1) and nuclear receptor coactivator 4 (NCOA4) (78). Here, NCOA4 is linked to glioblastoma.